Banasik 2011.
Study characteristics | ||
Methods | Study design: RCT Number randomized: 18; 9 to the exercise group and 9 to the control group Study start and stop dates: not reported Length of intervention: 8 weeks Length of follow‐up: to end of the intervention |
|
Participants | Type cancer: breast cancer, stages II to IV Time since cancer diagnosis: not reported Time beyond active treatment: at least 2 months' post‐treatment Inclusion criteria:
Eligibility criterion related to interest or ability to exercise, or both:
Exclusion criteria:
Gender: female Current age, mean (SD) years:
Age at cancer diagnosis: not reported Ethnicity/race: 100% Caucasian Education level: not reported SES, (n):
Employment status: not reported Comorbidities: not reported Past exercise history: not reported On hormone therapy: not reported |
|
Interventions | 9 participants assigned to the exercise intervention, including:
Type exercise (aerobic/anaerobic): aerobic Intensity of experimental exercise intervention: mild Frequency: twice per week Duration of individual sessions: 90 minutes Duration of exercise program: 8 weeks Total number of exercise sessions: 16 Format: group Facility: facility Professionally led: professionally led by expert Iyengar yoga instructors 9 participants assigned to control group, including:
Adherence: 7 women in the yoga group who completed the study attended an average of 14 of 16 possible yoga sessions (87.5%) with a range of 12 to 15 sessions Contamination of control group: not reported |
|
Outcomes | Outcomes include QoL, measured using the FACT‐B and subscales, including:
Outcomes were measured at baseline and at 8 weeks:
Subgroup analysis: not reported Adverse events: no cancer recurrences or adverse events reported |
|
Notes | Country: US Funding: University of Washington Center for Women's Health and Gender Research, Washington State University Cancer Prevention and Research Center, and the Washington State University College of Nursing |
|
Risk of bias | ||
Bias | Authors' judgement | Support for judgement |
Random sequence generation (selection bias) | Unclear risk | The generation of the random sequence was not described |
Allocation concealment (selection bias) | Unclear risk | Whether the treatment assignment was concealed from study personnel and participants was not described |
Blinding of participants and personnel (performance bias) All outcomes | High risk | Owing to the nature of the intervention, it was not possible to blind the participants; however, it is unclear whether the outcome was influenced by a lack of masking |
Blinding of outcome assessment (detection bias) All outcomes | High risk | Study personnel and outcome assessors were not masked or blinded to the study interventions |
Incomplete outcome data (attrition bias) All outcomes | High risk | There was no ITT analysis and it is unclear how missing data were handled. 2 participants in each group withdrew and no reason was given for withdrawal |
Selective reporting (reporting bias) | Low risk | There appears to be no selective reporting of outcomes |
Other bias | High risk | The small sample size and lack of description of the recruitment and selection of study participants could give rise to additional biases |